# Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia

> **NCT04255147** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Ottawa Hospital Research Institute** · enrollment: 9 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **BIOLOGICAL:** Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells

## Key facts

- **NCT ID:** NCT04255147
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-10-17
- **Primary completion:** 2023-11-06
- **Final completion:** 2033-11-06
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-07-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04255147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04255147, "Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04255147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*